Skip to main content
رجوع
NVCR logo

NovoCure Limited

جودة البيانات: 100%
NVCR
NASDAQ Healthcare Medical - Instruments & Supplies
KWD 11.61
▲ KWD 0.25 (2.20%)
القيمة السوقية: 1.32B
نطاق اليوم
KWD 11.47 KWD 11.83
نطاق 52 أسبوعًا
KWD 9.82 KWD 20.06
حجم التداول
1,076,841
متوسط 50 يوم / 200 يوم
KWD 12.55 / KWD 13.35
الإغلاق السابق
KWD 11.36

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E -9.7 0.3
P/B 3.9 3.0
ROE % -38.9 3.7
Net Margin % -20.8 3.8
Rev Growth 5Y % 5.2 10.0
D/E 0.9 0.2

السعر المستهدف للمحللين

Hold
KWD 33.50 +188.5%
Low: KWD 20.00 High: KWD 47.00
ربحية السهم المستقبلية
-KWD 1.51
الإيرادات المقدّرة
694.69M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 4.79
KWD 4.49 – KWD 5.35
1.84B 1
FY2029 KWD 2.45
KWD 2.30 – KWD 2.73
1.52B 1
FY2028 -KWD 0.42
-KWD 0.50 – -KWD 0.37
915.57M 3

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Revenue grew 5.20% annually over 5 years — modest growth
Negative free cash flow of -75.68M
PEG of 0.49 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.08%
Capital efficient — spends only 4.07% of revenue on capex

النمو

Revenue Growth (5Y)
5.20%
Revenue (1Y)8.28%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-38.89%
ROIC-18.30%
Net Margin-20.79%
Op. Margin-23.47%

الأمان

Debt / Equity
0.85
Current Ratio2.90
Interest Coverage0.00

التقييم

P/E Ratio
-9.70
Forward P/EN/A
P/B Ratio3.88
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 8.28% Revenue Growth (3Y) 13.43%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 5.20% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 655.35M Net Income (TTM) -136.23M
ROE -38.89% ROA -16.94%
Gross Margin 74.54% Operating Margin -23.47%
Net Margin -20.79% Free Cash Flow (TTM) -75.68M
ROIC -18.30% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.85 Current Ratio 2.90
Interest Coverage 0.00
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -9.70 Forward P/E N/A
P/B Ratio 3.88 P/S Ratio 2.02
PEG Ratio 0.49 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 1.90 Fwd Earnings Yield N/A
FCF Yield -5.73%
Market Cap 1.32B Enterprise Value 1.51B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 655.35M 605.22M 509.34M 537.84M 535.03M
Net Income -136.23M -168.63M -207.04M -92.53M -58.35M
EPS (Diluted) -1.22 -1.56 -1.95 -0.88 -0.56
Gross Profit 488.47M 468.04M 381.06M 422.97M 420.15M
Operating Income -153.80M -170.50M -232.87M -89.52M -44.33M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 804.33M 1.24B 1.15B 1.19B 1.14B
Total Liabilities 463.86M 880.61M 783.63M 750.48M 729.00M
Shareholders' Equity 340.47M 360.18M 362.50M 441.17M 410.49M
Total Debt 290.00M 683.35M 596.24M 584.27M 581.90M
Cash & Equivalents 103.39M 163.77M 240.82M 115.33M 209.61M
Current Assets 646.73M 1.11B 1.03B 1.11B 1.07B
Current Liabilities 223.23M 756.38M 179.12M 158.78M 142.60M